yoohning

Collected financial reports for Q1 2024 and the previous year from over 700 portfolio companies, screening for high-tech enterprises that met the new tax exemption requirements. Prepared draft disclosure documents, including annual reports, summarizing the performance of the company’s funds. Led end-to-end data governance for the company’s refinancing projects, responsible for dynamic maintenance of the OA system and multi-dimensional data validation.

Collected stock price trading data and built a dynamic visualization dashboard using Python (Matplotlib). Consolidated the approval status of innovative drugs developed by publicly listed companies in the pharmaceutical industry. Valued unlisted small and medium-sized enterprises in the Guangzhou-Foshan area using the discounted cash flow (DCF) method.